Literature DB >> 25684232

Orthostatic hypotension of unknown cause: Unanticipated association with elevated circulating N-terminal brain natriuretic peptide (NT-proBNP).

Balaji Krishnan1, Margarita Patarroyo-Aponte1, Daniel Duprez1, Marc Pritzker1, Emil Missov1, David G Benditt2.   

Abstract

BACKGROUND: The pathophysiology of orthostatic hypotension (OH) is multifactorial, with the most frequent causes being adverse effects of cardioactive drugs. In 20%-40% of cases, the etiology is unknown. In recent reports, altered levels of endogenous neuropeptides have been observed in noncardiac syncope, but B-type natriuretic peptide (BNP) and its amino-terminal cleavage fragment (NT-proBNP) have not been studied.
OBJECTIVE: The purpose of this study was to assess the possibility that BNP with its diuretic and vasorelaxant properties could contribute to OH.
METHODS: This prospective observational study comprised 85 consecutive OH subjects (58 women, age 49 ± 23 years) referred to a tertiary-care syncope clinic. All patients had normal left ventricular systolic and diastolic function, and clinical and laboratory findings consistent with euvolemia or modest hypovolemia. In 45 of 85 individuals (53%), an OH cause was determined.
RESULTS: Among the remaining 40 patients (21 women, age 57 ± 16 years) with OH of unknown cause, 6 of 40 (15%) exhibited unexpectedly elevated plasma NT-proBNP levels (14000, 5210, 2570, 7990, 3480, and 6680 pg/mL). In contrast, NT-proBNP values were normal (ie, <300 pg/mL) in the remaining 34 patients with OH of unknown cause and 45 patients with OH of known etiology. At 8 to 12 months of follow-up, volume repletion therapy requirements in patients with initial increased NT-proBNP diminished in conjunction with gradual fall of NT-proBNP concentrations.
CONCLUSION: In select patients, markedly elevated levels of BNP or NT-proBNP may be associated with and possibly contribute to symptomatic OH.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain natriuretic peptide; Natriuretic peptide; Orthostatic hypotension

Mesh:

Substances:

Year:  2015        PMID: 25684232     DOI: 10.1016/j.hrthm.2015.02.015

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  4 in total

1.  Comparison between men and women of volume regulating hormones and aquaporin-2 excretion following graded central hypovolemia.

Authors:  Nandu Goswami; Johannes Reichmuth; Annarita Di Mise; Bianca Brix; Andreas Roessler; Mariangela Centrone; Marianna Ranieri; Annamaria Russo; Natale Gaspare De Santo; Grazia Tamma; Ferdinando Carlo Sasso; Giovanna Valenti
Journal:  Eur J Appl Physiol       Date:  2018-12-18       Impact factor: 3.078

2.  B-type natriuretic peptide is upregulated by c-Jun N-terminal kinase and contributes to septic hypotension.

Authors:  Matthew Hoffman; Ioannis D Kyriazis; Alexandra Dimitriou; Santosh K Mishra; Walter J Koch; Konstantinos Drosatos
Journal:  JCI Insight       Date:  2020-04-23

3.  Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study.

Authors:  Cara Tomas; Andreas Finkelmeyer; Tim Hodgson; Laura MacLachlan; Guy A MacGowan; Andrew M Blamire; Julia L Newton
Journal:  Open Heart       Date:  2017-12-27

4.  Syndromes of orthostatic intolerance and syncope in young adults.

Authors:  Viktor Hamrefors; Jasmina Medic Spahic; David Nilsson; Martin Senneby; Richard Sutton; Olle Melander; Artur Fedorowski
Journal:  Open Heart       Date:  2017-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.